Johnson Johnson

Johnson & Johnson to stop selling talc-based baby powder: Why was the popular product always embroiled in controversy?

An investigation in 2018 found Johnson & Johnson knew about the presence of small amounts of asbestos, a known carcinogen, in its products from as early as 1971. The company currently faces about 38,000 lawsuits from consumers with many claiming its talc products caused cancer

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

In December, the Centers for Disease Control and Prevention recommended Moderna and Pfizer shots over J&J's because of its safety issues.

US opioid crisis: Pharma giants to pay $590 million to Native Americans to settle claims

The US opioid crisis has claimed more than 500,000 lives over the last 20 years and ensnared some of the largest firms in the world of American medicine

Omicron can evade protection offered by COVID-19 vaccines, antibody therapies, says study

The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve.

India may try to find 'middle ground' for usage and export of J&J single-shot jab

A strategy needs to be put in place where India may take a share of the monthly production of J&J’s vaccine for domestic use, said a senior government official privy to developments on this front

FDA nod for Pfizer COVID-19 boosters for seniors, high-risk but hurdles remain

The US has already authorised third doses of the Pfizer and Moderna vaccines for certain people with weakened immune systems such as cancer patients and transplant recipients

How does the COVID-19 vaccine work once it enters the body – Roadmap for kids and adults

As soon as the vaccine is inside the tissue cells, it uses the instructions to create spike proteins. This process usually takes less than 12 hours.

Johnson & Johnson files application to test its COVID vaccine on adolescents; all you need to know

The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children

India's daily coronavirus cases dip below 40,000 for second day; 9 states, UTs still reporting upward trend

The number of people who have recuperated from the disease surged to 3,10, 99,771, while the case fatality rate stands at 1.34 per cent, the data stated.

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population

J&J earlier had sought approval to conduct phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups---those aged 18 and below 60 years and those aged 60 years and above---to evaluate the safety, reactogenicity and immunogenicity of the jab in healthy Indian adults.